Quality of life (QoL) in ovarian cancer patients following hyperthermic intraperitoneal chemotherapy (HIPEC) versus intraperitoneal (IP) chemotherapy

被引：0
|
作者：
Dellinger, T. [1 ]
Lee, S. J. [1 ]
Sun, V. [1 ]
Ruel, N. H. [1 ]
Liu, X. [1 ]
Lin, W. C. M. [1 ]
Kebria, M. [1 ]
Han, E. S. [1 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.496
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2309
引用
收藏
页码：214 / 214
页数：1
相关论文
共 50 条
  • [21] Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
    van Driel, W. J.
    Koole, S. N.
    Sikorska, K.
    van Leeuwen, J. H. Schagen
    Schreuder, H. W. R.
    Hermans, R. H. M.
    de Hingh, I. H. J. T.
    van der Velden, J.
    Arts, H. J.
    Massuger, L. F. A. G.
    Aalbers, A. G. J.
    Verwaal, V. J.
    Kieffer, J. M.
    Van de Vijver, K. K.
    van Tinteren, H.
    Aaronson, N. K.
    Sonke, G. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (03): : 230 - 240
  • [22] Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
    Julia H. Gelissen
    Naomi N. Adjei
    Blair McNamara
    Levent Mutlu
    Justin A. Harold
    Mitchell Clark
    Gary Altwerger
    Peter R. Dottino
    Gloria S. Huang
    Alessandro D. Santin
    Masoud Azodi
    Elena Ratner
    Peter E. Schwartz
    Vaagn Andikyan
    Annals of Surgical Oncology, 2023, 30 : 5597 - 5609
  • [23] Hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer: The Cleveland Clinic experience
    Costales, A. B.
    Chambers, L. Moulton
    Chichura, A. M.
    Rose, P. G.
    Mahdi, H.
    Michener, C. M.
    Yao, M.
    DeBernardo, R.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 257 - 258
  • [24] Current status of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in the United States
    Charo, Lindsey M.
    Jou, Jessica
    Binder, Pratibha
    Hohmann, Samuel F.
    Saenz, Cheryl
    McHale, Michael
    Eskander, Ramez N.
    Plaxe, Steven
    GYNECOLOGIC ONCOLOGY, 2020, 159 (03) : 681 - 686
  • [25] The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review
    Bhatt A.
    Glehen O.
    Indian Journal of Surgical Oncology, 2016, 7 (2) : 188 - 197
  • [26] Transcriptomic analysis of hyperthermic intraperitoneal chemotherapy (HIPEC) in a cellular model of ovarian cancer
    Horowitz, M. P.
    Esakov, E. L.
    Hong, C.
    Michener, C. M.
    Rose, P. G.
    Hwang, T. H.
    DeBernardo, R.
    Reizes, O.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 154 - 155
  • [27] Feasibility and pharmacokinetics of intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) with paclitaxel following cytoreductive surgery in ovarian cancer patients
    De Bree, E.
    Rosing, H.
    Filis, D.
    Romanos, J.
    Melissourgaki, M.
    Daskalakis, M.
    Pilatou, M.
    Sanidas, E.
    Beijnen, J. H.
    Tsiftsis, D. D.
    EJC SUPPLEMENTS, 2007, 5 (04): : 320 - 321
  • [28] Cost-effectiveness of hyperthermic intraperitoneal chemotherapy HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy
    Lim, Stephanie L.
    Havrilesky, Laura J.
    Habib, Ashraf S.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2019, 153 (02) : 376 - 380
  • [29] COST-EFFECTIVENESS OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) AT INTERVAL DEBULKING OF EPITHELIAL OVARIAN CANCER FOLLOWING NEOADJUVANT CHEMOTHERAPY
    Lim, S.
    Havrilesky, L.
    Cohn, D.
    Habib, A.
    Secord, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 627 - 627
  • [30] Role of hyperthermic intraperitoneal chemotherapy in ovarian cancer
    Manuel Medina-Castro, Juan
    Ruiz-DeLeon, Adriana
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (04)
12345